Most Read Articles
5 days ago
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
4 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
2 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 4 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.

6-minute walk test reproducible, useful in systemic sclerosis

07 Oct 2018

A recent study has demonstrated the robust reproducibility for the 6-minute walk distance (6MWD) and established the utility of the 6-minute walk test (6MWT) in examining the overall prognosis of patients with systemic sclerosis (SSc).

In total, 56 patients (aged 46±12.7 years; 38 female), with 17±10 modified Rodnan skin score (mRSS) and 1±0.8 Scleroderma Health Assessment Questionnaire (SHAQ) at first referral, were included. Overall, 277 6MWT assessments (5±3.9 6MWT per patient) were conducted over 23±22.5 months of follow-up. There were eight deaths (87.5 percent SSc-related) reported.

The 6MWD absolute value had a mean of 457±117 m, with a mean Borg dyspnoea score of 4±2.2. The 6MWD intraclass correlation coefficient was 0.996 (95 percent CI, 0.995–0.999; p<0.0001).

Multivariate linear regression analysis showed the following factors to be independently associated with a lower 6MWD: sex (R2, 0.47; p<0.0001), mRSS (R2, 0.47; p=0.008), tendon friction rub (R2, 0.47; p=0.003), SHAQ (R2, 0.47; p=0.02), muscle disability score (R2, 0.47; p=0.03), DLCO% (R2, 0.47; p=0.0008), and left ventricular ejection fraction (R2, 0.47; p=0.006).

The 6MWD at first referral independently predicted overall mortality (hazard ratio [HR], 0.99; 0.988–0.999) and SSc-related mortality (HR, 0.99; 0.988–0.999).

This observational study consecutively enrolled all patients with SSc who underwent at least two 6MWT within a minimum 3-month interval plus simultaneous routine clinical, biological and functional evaluations over 6 years. In compliance with the American Thoracic Society guidelines, each 6MWT was repeated twice to assess the reproducibility of the 6MWD, with the highest value being reported for subsequent analysis.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
4 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
2 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 4 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.